M
Min Xie
Researcher at Huazhong University of Science and Technology
Publications - 64
Citations - 2896
Min Xie is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Asthma & Medicine. The author has an hindex of 14, co-authored 52 publications receiving 1852 citations. Previous affiliations of Min Xie include Chinese Ministry of Health & Shanxi Medical University.
Papers
More filters
Journal ArticleDOI
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.
Xiaochen Li,Xiaochen Li,Shuyun Xu,Shuyun Xu,Muqing Yu,Muqing Yu,Ke Wang,Ke Wang,Yu Tao,Yu Tao,Ying Zhou,Ying Zhou,Jing Shi,Jing Shi,Min Zhou,Min Zhou,Bo Wu,Zhenyu Yang,Zhenyu Yang,Cong Zhang,Cong Zhang,Junqing Yue,Junqing Yue,Zhiguo Zhang,Harald Renz,Xiansheng Liu,Xiansheng Liu,Jungang Xie,Jungang Xie,Min Xie,Min Xie,Jianping Zhao,Jianping Zhao +32 more
TL;DR: Survival analysis revealed that male, elder age, leukocytosis, high LDH level, cardiac injury, hyperglycemia, and high-dose corticosteroid use were associated with death in patients with severe COVID-19.
Journal ArticleDOI
Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017
Xiaochen Li,Xiaopei Cao,Xiaopei Cao,Mingzhou Guo,Mingzhou Guo,Min Xie,Xiansheng Liu,Xiansheng Liu +7 more
TL;DR: Assessment of the factors responsible for regional variations in mortality and DALYs and the unequal distribution of improvements during the 27 years showed negative correlations between the Socio-demographic index and the mortality rates of COPD, pneumoconiosis, and asthma.
Journal ArticleDOI
Asthma-associated risk for COVID-19 development.
TL;DR: The concept that patients suffering from different asthma endotypes present with a different risk profile in terms of SARS-CoV-2 infection, development of CO VID-19, and progression to severe COVID-19 outcomes is proposed.
Journal ArticleDOI
Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan.
Lu Qin,Lu Qin,Xiaochen Li,Xiaochen Li,Jing Shi,Jing Shi,Muqing Yu,Muqing Yu,Ke Wang,Ke Wang,Yu Tao,Yu Tao,Ying Zhou,Ying Zhou,Min Zhou,Min Zhou,Shuyun Xu,Shuyun Xu,Bo Wu,Zhenyu Yang,Zhenyu Yang,Cong Zhang,Cong Zhang,Junqing Yue,Junqing Yue,Chongsheng Cheng,Chongsheng Cheng,Xiansheng Liu,Xiansheng Liu,Min Xie,Min Xie +30 more
TL;DR: The gendered differences in inflammation reaction, and the association with severity and mortality of COVID‐19 are studied to study the underlying mechanism of sex predisposition.
Journal ArticleDOI
Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017
Min Xie,Min Xie,Xiansheng Liu,Xiansheng Liu,Xiaopei Cao,Xiaopei Cao,Mingzhou Guo,Mingzhou Guo,Xiaochen Li,Xiaochen Li +9 more
TL;DR: The ASIRs of CRD, chronic obstructive pulmonary disease, pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years, and Statistically significant correlation was found between the ASir and SDI/HDI.